"financial analyses" is a correct and usable part of a sentence in written English.
It is typically used when discussing detailed examinations or evaluations of financial data or information. Example: "The company's board of directors requested several financial analyses before making a decision on the proposed merger."
Jeffrey A. Landers, CDFA™ is a Divorce Financial Strategist™ and the founder of Bedrock Divorce Advisors, LLC, a divorce financial strategy firm that exclusively works with women, who are going through, or might be going through, a financially complicated divorce (we provide financial analyses and projections, not legal services).
That is according to data from Sageworks, which does financial analyses of private companies.
I helped to introduce a program, for example, that let the sales staff show financial analyses to prospective customers.
As in a conventional situation, financial analyses will form the basis for the written opinion.
Despite legislative leaders' assertions that they undertake independent financial analyses of the pension bills, neither the Senate nor the Assembly could provide any records to bolster that claim.
But instead of telling the 2,116 outside shareholders the news, Alticor issued a series of misleading statements and financial analyses to shareholders.
Copula theory is a typical method in this area, which has been widely applied in financial market analyses, portfolio investments, and risk assessments [14, 15].
Not only institutions benefit from the advantages of short-term financial data analyses; smaller investors can benefit, as well.
A vast network of federal, state and local regulation now reaches deeply into institutional life, demanding a public viewing of academic entrails once relegated to musty files in the Dean's Office or Registrar: retention and completion rates, disciplinary proceedings, crime stats, financial aid analyses and Title IX data.
The companies – which include Barclays, HSBC, and London Stock Exchange Group – shared data confidentially with the Treasury, which anonymised it before passing it to New Financial to analyse.
DMPA products issued at primary health care outlets in the three financial years analysed were obtained from the original patent holder (Pharmacia-Upjohn) and a generic manufacturer (Aspen Pharmacare).
